Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-02-15

FDA Tentative Approval: SAXAGLIPTIN — Original Application (Glenmark Pharmaceuticals Inc., USA)

View source ↗

Summary

FDA tentatively approves Glenmark's generic saxagliptin (SAXAGLIPTIN) under an ANDA for type 2 diabetes mellitus, subject to patent and exclusivity consideratio…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Saxagliptin (saxagliptin)

Snippet

ORIG TA for SAXAGLIPTIN (SAXAGLIPTIN)